The quality of prescribing in general practice in Kerman, Iran

International Journal of Health Care Quality Assurance

Volumn 18, Issue 5, 2005, Pages 353-360

  Gholamreza Sepehri, ^a   Manzumeh Shamsi, Meimandi ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotics; General practitioners; Iran; Medical prescriptions

Indexed keywords

ARTICLE; CLINICAL PRACTICE; GENERAL PRACTICE; HEALTH CARE QUALITY; IRAN; PRESCRIPTION;

FAMILY PRACTICE; IRAN; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; QUALITY ASSURANCE, HEALTH CARE;

EID: 23944502047     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526860510612207     Document Type: Article

References (36)

1. Agaba, E.I., Agaba, P.A. and Wigwe, G.M. (2004), "Use and abuse of analgesics in Nigeria: a community survey", Nigerian Journal of Medicine, Vol. 13 No. 4, pp. 379-82.
2. Al-Faris, E.A. and Al-Taweel, A. (1999), "Audit of prescribing patterns in Saudi primary health care: what lessons can be learned?", Annals Saudi Medicine, Vol. 19 No. 4, pp. 317-21.
3. Anandkumar, H., Kapur, I. and Dayanand, A. (2003), "Increasing prevalence of antibiotic resistance and multi-drug resistance among uropathogens", J. Commun. Dis., Vol. 35, pp. 102-8.
4. Armstrong, D. (1998), "Social patterns of illness", in Armstrong, D. (Ed.), An Outline of Sociology as Applied to Medicine, John Wright, London, pp. 43-51.
5. Barber, N. (1995), "What constitutes good prescribing?", British Medical Journal, Vol. 310 No. 6984, pp. 923-5.
6. Britten, N. and Ukoumunne, O. (1997), "The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey", British Medical Journal, Vol. 315 No. 7121, pp. 1506-10.
7. Classen, D.C., Pestonik, S.L., Evans, R.S., Lloyd, J.F. and Bruke, J.P. (1997), "Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality", Journal of the American Medical Association, Vol. 277 No. 4, pp. 301-6.
8. Doupe, M., Katz, A., Kvem, B., Manness, L.J., Metge, C., Thomson, G.T., Morrison, L. and Rother, K. (2004), "Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial", BMC Health Services Research, Vol. 14 No. 1, p. 21.
9. Dowell, S.F., Marcy, S.M. and Phillips, W.R. (1998), "Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections", Pediatrics, Vol. 101, pp. S63-5, (supplement).
10. El Maghraoui, A. (2004), "Corticosteroid-induced osteoporosis", Presse Med., Vol. 33 No. 17, pp. 1213-17.
11. Figueiras, A., Caamano, F. and Gestal-Otero, J.J. (2000), "Influence of physicians' education, drug information and medical-care settings on the quality of drugs prescribed", European Journal of Clinical Pharmacology, Vol. 56 Nos 9-10, pp. 747-53.
12. Forder, A.A. (1995), "How best to utilize limited resources", Journal of Hospital Infections, Vol. 30, pp. 15-25, (supplement).
13. Gadomski, A.M. (1993), "Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections", Pediatric Infectious Disease Journal., Vol. 12 No. 2, pp. 115-20.
14. Gilson, L., Kitange, H. and Tuescher, T. (1993), "Assessment of process quality in Tanzanian primary care", Health Policy, Vol. 26 No. 2, pp. 119-39.
15. Hamadeh, G.N., Dickerson, L.M., Saab, B.R. and Major, S.C. (2001), "Common prescriptions in ambulatory care in Lebanon", Annals Pharmacotherapy, Vol. 35 No. 5, pp. 636-40.
16. Hogerzeil, H.V. (1995), "Promoting rational prescribing: an international perspective", British Journal of Clinical Pharmacology, Vol. 39, pp. 1-6.
17. Hogerzeil, H.V., Walker, G.J., Sallami, A.O. and Fernando, G. (1989), "Impact of an essential drugs programme on availability and rational use of drugs", Lancet, Vol. 1 No. 8630, pp. 141-2.
18. Hogerzeil, H.V., Bimo, B., Ross-Degnan, D., Laing, R.O., Ofori-Adjei, D., Santoso, B., Azad, C.A.K., Das, A.M., Kafle, K.K. and Mabadeje, A.F. (1993), "Field tests for rational drug use in 12 developing countries", Lancet, Vol. 342, pp. 1408-10.
19. Holloway, K. (2000), "Who contributes to misuse of antimicrobials?", Essential Drugs Monitor, Vol. 9 Nos 28-29, p. 9.
20. Imam, A.P. and Halpern, G.M. (1994), "Uses, adverse effects of abuse of corticosteroids, Part I", Allergology Immunopathology (Madr.), Vol. 22 No. 6, pp. 250-60.
21. Kroenke, K. (1985), "Polypharmacy. Causes, consequences, and cure", American Journal of Medicine, Vol. 79 No. 2, pp. 149-52.
22. Laing, R.O., Hogerzeil, H.V. and Ross-Degnan, D. (2001), "Ten recommendations to improve use of medicines in developing countries", Health Policy Plan., Vol. 16 No. 1, pp. 13-20.
23. Lazarou, J., Pomeranz, B.H. and Corey, P.N. (1998), "Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies", Journal of the American Medical Association, Vol. 279 No. 15, pp. 1200-5.
24. Logez, S., Hutin, Y., Holloway, K., Gray, R. and Hogerzeil, H.V. (2004), "Could the WHO model list of essential medicines do more for the safe and appropriate use of injections?", Journal of Clinical Pharmacology, Vol. 44 No. 10, pp. 1106-13.
25. Moghadamnia, A.A., Mirbolooki, M.R. and Aghili, M.B. (2002), "General practitioner prescribing patterns in Babol city, Islamic Republic of Iran", East Mediterranean Health Journal, Vol. 8 Nos 4-5, pp. 550-5.
26. Otoom, S., Batieha, A., Hadidi, H., Hasan, M. and Al-Saudi, K. (2002), "Evaluation of drug use in Jordan using WHO prescribing indicators", East Mediterranean Health Journal, Vol. 8 Nos 4-5, pp. 537-43.
27. Petrie, J.C., Grimshaw, J.M. and Bryson, A. (1995), "The Scottish Intercollegiate Guidelines Network Initiative: getting validated guidelines into local practice", Health Bulletin, Vol. 53 No. 6, pp. 345-8.
28. Pont, L.G. (1998), "Appropriate prescribing in general practice: development of indicators", Quality in Health care, Vol. 7, p. 123.
29. Quick, J.D., Hogerzeil, H.V., Velasquez, G. and Rago, L. (2002), "25 years of essential medicines", Bulletin of the World Health Organization, Vol. 80 No. 11, pp. 913-14.
30. Simonsen, L., Kane, A., Lloyd, J., Zaffran, M. and Kane, M. (1999), "Unsafe injections in the developing world and transmission of blood-borne pathogens: a review", Bulletin of the World Health Organization, Vol. 77 No. 10, pp. 789-800.
31. Simpson, G.B. and Govinda Das, D. (2003), "Indian hospital drug use study shows need to improve prescribing", Essential Drugs Monitor, Vol. 32, p. 23.
32. Stollberger, C. and Finsterer, J. (2004), "Side-effects of conventional non-steroidal anti-inflammatory drugs and celecoxib: more similarities than differences", Southern Medical Journal, Vol. 97 No. 2, p. 209.
33. Ulinski, T. and Bensman, A. (2004), "Renal complications of non-steroidal anti-inflammatories", Archives Pediatrics, Vol. 11 No. 7, pp. 885-8.
34. Uppal, R., Sarkar, V., Giriyappanavar, C. and Kacker, V. (1993), "Antimicrobial drug use in primary health care", Joural of Clinical Epidemiology, Vol. 46 No. 7, pp. 671-3.
35. WHO (1993), WHO Action Programme on Essential Drugs and Vaccines: How to Investigate Drug Use in Health Facilities: Selected Use Indicators, DAP Research Series No. 7, World Health Organization, Geneva.
36. Williams, R. (2000), "Antimicrobial resistance: the facts", Essential Drugs Monitor, Vol. 28-29, pp. 7-8.